Technology | April 07, 2008

Itamar Medical's Endo-PAT2000 Measures Endothelial Dysfunction


Itamar Medical's Endo-PAT2000 is an FDA-cleared device used to assess endothelial function.

Endo-PAT2000 was used in a clinical study (Vaclavik et al. Indoor Particles Affect Vascular Function in the Aged. American Journal of Respiratory and Critical Care Medicine 2008; Vol 177. pp. 419-425) for evaluating the effect of high-efficiency particulate air (HEPA) filters on endothelial function, an indicator of cardiovascular health.

Both short-term and long-term exposure to ambient levels of particulate are associated with increased fatalities related to respiratory and cardiovascular disease. Researchers in the study believe endothelial dysfunction, which is a strong predictor of adverse cardiovascular conditions, may be the source of this increase in respiratory and cardiovascular diseases.


Additional Content

News | Cardiac Diagnostics

March 4, 2026 — Inflo Health has launched a comprehensive cardiology suite designed to address care management gaps ...

Home March 04, 2026
Home
News | Cardiac Diagnostics

Feb. 26, 2026 — Eko Health has partnered with Wayne General Hospital in Wayne County, Mississippi, to deploy SENSORA, an ...

Home February 26, 2026
Home
News | Cardiac Diagnostics

Nov. 12, 2025 — AISAP, a provider of AI Point-of-Care Diagnostics, has announced a field initiative in Ghana, deploying ...

Home November 12, 2025
Home
News | Cardiac Diagnostics

June 11, 2025 — MorningStar Laboratories, LLC, a developer of precision diagnostic tests that address unmet clinical ...

Home June 16, 2025
Home
News | Cardiac Diagnostics

Aug. 13, 2024 – The traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for ...

Home August 15, 2024
Home
Subscribe Now